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Background and purpose   The reproducibility of results and 
potential confounders in sample-based studies is important to 
consider in the assessment of studies. Comprehensive arthroplasty 
registers could serve as a reference dataset for comparative analy-
ses. We analyzed an implant that is frequently used worldwide, 
the Oxford unicompartmental knee replacement, in order to iden-
tify potential confounders inherent in the datasets and to evaluate 
the outcome achieved with this implant.
Methods   We performed a structured literature review of 
the data published on the revision rate of the Oxford medial 
unicompartmental arthroplasty. Both clinical follow-up studies 
and worldwide registry data were included. Confidence intervals 
were calculated to determine the statistical significance of differ-
ences.
Results   A substantial proportion of the published data (52–
68% depending on the method of calculation) is derived from 
studies involving participation of the institution that developed 
the implant. The results published by this group show a statis-
tically significant deviation from the reference datasets from 
registers or independent studies. Data from the developing hos-
pital show mean revision rates that are 4 times lower than those 
based on worldwide register data, and 3 times lower than the ones 
quoted in independent studies. On average, the data published in 
independent studies are reproducible in registry data.
Interpretation   A conventional meta-analysis of clinical studies 
is substantially affected by the influence of the developing hospi-
tal, and is therefore subject to bias. For assessment of the outcome 
of implants, registry data are superior and, in terms of reference 
data for the detection of potential bias factors in the literature, 
could make an essential contribution to meta-analyses.
 
Two main data sources are available for the assessment of the 
outcome of arthroplasty: sample-based clinical studies and 
national arthroplasty registries. Compared to clinical follow-
up studies, registry data feature several essential differences 
(Graves 2010). 
Clinical studies are mainly conducted in specialized centers 
that are not representative of the average orthopedic center 
in all aspects, for example, regarding the number of patients 
treated and, as a consequence, the training of staff and their 
personal expertise. Study design or patient selection may 
introduce further bias factors. Even publication bias can have 
a potentially relevant effect on the data published.
National arthroplasty registers, by contrast, include all sur-
geries performed in a country and can thus avoid or consider-
ably reduce these bias factors. On the other hand, data from 
registries reflect the circumstances under which they were 
collected, such as surgical procedures or the respective public 
health system, and can thus have an impact on the outcome. 
Also, the evaluation procedures applied, such as designation 
of implant variants to cohorts, could possibly lead to misinter-
pretations (Labek et al. 2008).
The expectation that published results can be reproduced in 
their own practice is essential for the readers of scientific lit-
erature. This is equally true for the assessment of implants and 
decisions by health authorities, since published scientific find-
ings are considered in a variety of decision-making processes. 
In general one should take into consideration that results 
presented in scientific literature would not be expected to be 
deterministic, but subject to random and sampling errors that 
can be calculated and described using confidence intervals.
One of the tasks of the EU Commission’s EUPHORIC 
(European Public Health Outcome Research and Indica-
tor Collection) project was to examine the extent to which 
published data are reproducible in an average situation. The 
objective was to identify potential bias factors and to develop 
a suitable methodology for this particular purpose. Data from 
complete and high-quality national registries were used as ref-132  Acta Orthopaedica 2011; 82 (2): 131–135
erence benchmark values reflecting the outcome in average 
patient service.
The Oxford unicompartmental prosthesis has been one 
of the most frequently used implants in the field of knee 
arthroplasty worldwide for many years, particularly for the 
isolated replacement of the medial compartment. We criti-
cally analyzed the outcome of the Oxford unicompartmental 
implant and the quality of the published literature dealing with 
this implant.
Materials and methods
We conducted a web-based literature search using PubMed as 
a first step. This was followed by a manual literature search, 
and also a direct request for literature from the manufacturer 
of the implant. 
The inclusion criteria for consideration in the subsequent 
evaluation were: unambiguous identification of the implant, 
revision rate data either presented in the text or unambigu-
ously calculable from the data therein, English or German lan-
guage publications in Medline-listed, peer-reviewed journals.
23 publications were identified and analyzed in full text 
(Goodfellow et al. 1988, Carr et al. 1993, Lewold et al. 1995, 
Murray et al. 1998, Vorlat et al. 2000, 2006, Svärd and Price 
2001, Emerson and Higgins 2004, 2008, Jahromi et al. 2004, 
Lisowski et al. 2004, Rajasekhar et al. 2004, Langdown et al. 
2005, Price et al. 2005 a,b, Verdonk et al. 2005, Pandit 2006, 
Vorlat et al. 2006, Berend et al. 2007, Kort et al. 2007a, b, 
Luscombe et al. 2007, Koskinen et al. 2007, 2008). 20 of these 
publications were monocenter studies and 3 of them were 
based on multicenter evaluations (Langdown et al. 2005, Price 
et al. 2005b. Vorlat et al. 2006).
Clinical follow-up studies were compared to datasets from 
arthroplasty registers. The analysis included journal publica-
tions as well as annual registry reports that were accessible 
via http://www.efort.org/getdoc/1b923b01-41d2-4587-bac2-
7ca7a11e613e/Arthoplasty-Registers.aspx. 3 journal publi-
cations were available from arthroplasty registers in Finland 
and Sweden (Lewold et al. 1995, Koskinen et al. 2007, 2008). 
Annual reports were available from Australia (Annual Report 
2008), Sweden (Annual Report 2007), and Finland (2006 
Implant Yearbook). These allowed derivation of the values 
required for indicator calculation.
The main evaluation criterion was the indicator ‘revi-
sion rate’, a variation of which, ‘revisions per 100 observed 
component years’, was used for the comparative assessment. 
It was applied in accordance with the Australian National 
Arthroplasty Registry’s definition (Australian National Joint 
Replacement Registry Annual Report 2008).
The basic idea of this parameter is to summarize all patients’ 
individual years after surgery as ‘observed component years’, 
during which they are at risk of revision (no. of cases × aver-
age follow-up period), and to compare this value with the 
number of revisions observed in this cohort. This method of 
evaluation allows considering the number of cases and the 
follow-up period in any publication with respect to its impact 
on the average results. Larger studies and longer follow-up 
periods are given higher weight in the calculation due to the 
higher number of observed component years. This proce-
dure enables direct comparison of different studies and data 
sources expressed in one value. A value of 1 revision per 100 
observed component years corresponds to a revision rate of 
5% at 5 years or a 10% revision rate at 10 years in conven-
tional follow-up studies.
The journal publications were analyzed regarding the source 
of publication, authors, geographic region, number of cases, 
and follow-up period. Any publication indicating the Nuffield 
Orthopaedic Centre in Oxford and/or the Nuffield Department 
of Orthopaedics, Rheumatology and Musculoskeletal Sci-
ences of the University of Oxford as the contact address and/
or naming Prof. Goodfellow or Prof. Murray as authors or co-
authors was rated as a ‘publication by the development team’. 
For all data sources, all data were pooled in a standardized 
way. For each parameter, with the exception of follow-up 
times, exact values were required for inclusion in the study. If 
no specific follow-up times, but mere follow-up periods were 
given, a linear distribution of cases was assumed.
To determine statistical significance, 95% confidence inter-
vals (CIs) were calculated. Confidence intervals were cal-
culated using Circulator software version 4, an Excel-based 
program from the University of Adelaide. Further statistical 
evaluations were not performed owing to variability in the 
basic data and in the designs of the studies included.
Results
20 of the 23 publications were conventional clinical follow-up 
studies (Goodfellow et al. 1988, Carr et al. 1993, Murray et al. 
1998, Vorlat et al. 2000, Svärd and Price 2001, Emerson and 
Higgins 2004, 2008, Jahromi et al. 2004, Lisowski et al. 2004, 
Rajasekhar et al. 2004, Langdown et al. 2005, Verdonk et al. 
2005, Price et al. 2005a, b, Pandit 2006, Vorlat et al. 2006, 
Berend et al. 2007, Price et al. 2005a, b, Price et al. 2005, 
2007, Kort et al. 2007a, b, Luscombe et al. 2007), 7 of which 
came from the developing hospital in Oxford (Goodfellow et 
al. 1988, Carr et al. 1993, Murray et al. 1998, Langdown et al. 
2005, Price et al. 2005a, b, Pandit 2006). 3 journal publica-
tions were based on data from national registers (Lewold et al. 
1995, Koskinen et al. 2007, 2008).
The majority of these publications were of European origin.
Length of follow-up
With an average follow-up of 10 years, the follow-up periods 
of the development team were double those referred to in the 
independent studies, where the average was 5 years. With a 
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publications from the developing hospital was slightly higher 
than the number of cases from independent users’ clinics, 
comprising 1,445 patients. 52% of all cases were published by 
authors from the developing hospital. 
Studies from the inventor hospital compared to inde-
pendent studies
Of the total population presented in clinical studies (compris-
ing 3,004 cases), 155 had to undergo revision surgery. This 
corresponds to a proportion of revisions of 5.2%. With a value 
of 0.45 (CI: 0.35–0.57), the probability of reoperation accord-
ing to the ‘revisions per 100 observed component years’ indi-
cator was statistically significantly lower in the developing 
hospital than the values quoted in the independent studies, 
where the comparative value was 1.2 (CI: 0.99–1.5). The revi-
sion rate published in papers from the developing hospital was 
therefore 2.7 times lower than in independent studies, a differ-
ence that is statistically significant.
Summarizing the data, as is done in conventional meta-anal-
yses, yielded a revision probability of 0.70 (CI: 0.60–0.82) 
revisions per 100 observed component years. This outcome 
differed statistically significantly from the average value pub-
lished by the development team from Oxford, but not from 
that derived from independent publications. 3 journal publica-
tions were based on data from national registries in Sweden 
and Finland (Lewold et al. 1995, Koskinen et al. 2007, 2008) 
(Table 1).
Registry data
Analysis of the annual national arthroplasty registry reports 
of Australia, Finland, and Sweden revealed average outcomes 
ranging from 1.7 to 2.3 revisions per 100 observed component 
years, with Sweden achieving the best results. The differences 
showed a maximum factor of 1.2 though, and were not statisti-
cally significant (Table 2).
A comparison of annual reports and journal publications 
from registries showed considerably longer follow-up peri-
ods, with a smaller number of patients involved in the journal 
publications. Since journal publications are based on defined 
cohorts to examine specific topics such as long-term outcome, 
this result is not surprising. There were no statistically signifi-
cant differences in revision rate.
The average deviations between individual register-based 
studies were also very low, and they were not statistically sig-
nificant. The average value for all studies deviated from the 
average comprehensive, worldwide registry data by a factor 
of 1.2.
Registry-based studies compared to studies from the 
developing hospital
At an average of 9 years, the follow-up periods for publica-
tions based on registry datasets were similar to those for the 
developing hospital. The number of cases included in regis-
try publications was larger by a factor of 1.3, and was thus 
in a comparable range. At 1.6 (CI: 1.4–1.8) revisions per 100 
observed component years, the revision probability shown in 
this dataset exceeded that quoted in the developers’ publica-
tions by a factor of 3.6. This difference was statistically sig-
nificant.
In the comprehensive datasets of arthroplasty registries, a 
value of 2 (CI: 1.8–2.1) revisions per 100 observed compo-
nent years became apparent. Thus, the revision rate was 4.4 
Table 2. Outcome of the Oxford unicompartmental knee arthroplasty, by country 
  Follow-up  Revisions/   No. of  No. of  Observed  Revisions per   CI  Factor 
  period  primaries  primary  revision  component  100 observed    difference to
    (%)  cases  cases  years  component years    the average
    
Australian Registry  3.55  6.88  8,644  595  30,720  1.9  1.8–2.1  0.97
Finnish Registry  2.72  6.23  2,361  147  6,417  2.3  2.0–2.7  1.2
Swedish Registry  5  8.5  980  83  4,900  1.7  1.4–2.1  0.86
Total/Average  3.51  6.88 11,985  825 42,037  2.0  1.8–2.1 
Sources: Australia: Annual Report 2008; Finland: Yearbook 2006; Sweden: Annual Report 2007.
Table 1. Description of basic data with respect to data source
  No. of  Follow-up  Revisions/  No. of  No. of  Observed  Revisions per   CI 
  publications  period  primaries  primary  revision  component  100 observed
       (%)  cases  cases  years  component years
Inventor studies  7  9.6  4.3  1,559  67  15,029  0.45 0.35–0.57
Independent clinical studies  13  5.0  6.1  1,445  88  7,205  1.22 0.99–1.50
Total clinical studies  20  7.4  5.2  3,004  155  22,234  0.70  0.60–0.82
Registry-based journal publications  3  9.0  14.5  1,951  283  17,638  1.60  1.43–1.80
Annual registry reports  3  3.5  6.9 11,985  825  42,037  1.96 1.83–2.10134  Acta Orthopaedica 2011; 82 (2): 131–135
times higher than in the developers’ publications and 2.7 times 
higher than in the average of all sample-based journal publica-
tions. The differences between the datasets of clinical studies 
by implant developers and pooled data were statistically sig-
nificant, which was not, however, the case for the difference 
between inventor studies and independent studies.
Registry-based studies compared to independent 
studies
The difference between inventor-independent studies and reg-
istry-based journal publications only amounted to a factor of 
1.3, and to a factor of 1.6 in comparison with annual reports 
of national arthroplasty registries; comparison of the cumula-
tive value of all clinical publications to the values recorded 
in national arthroplasty registry reports yielded a difference 
factor of 2.8. This higher value clearly reflects the influence of 
publications from the inventor hospital.
General considerations
When assessing the clinical relevance of the differences 
detected, one should take into account the usual deviation of 
individual hospitals or datasets from the mean. The national 
registries of Sweden and Denmark publish such data. Here, 
the best national hospitals deviated from the mean by a factor 
of 2–3 at most (Danish Hip Arthroplasty Register Annual 
Report 2006, Swedish Hip Arthroplasty Register Annual 
Report 2007; Swedish Knee Register Annual Report 2009). 
Deviations within these limits can therefore be assumed to 
be plausible and to represent differences in revision rates that 
may be caused cumulatively, e.g. due to personal skills, in-
house standards and quality assurance, or patient selection.
Discussion
The average results on the implant published by the inven-
tor team differed markedly from the outcome published in 
independent clinical studies or shown by worldwide national 
arthroplasty registry data. They also exceeded the maximum 
deviation of individual departments (due to factors such as 
personal expertise and patient selection) from the national 
mean that has been registered for hip and knee prostheses in 
countries such as Sweden and Denmark.
The cause of this divergence can only be an issue for specu-
lation. Irrespective of the reasons for these deviations, how-
ever, the average surgeon should be aware of the fact that 
the outcome published by the inventing center appears to be 
hardly reproducible in average patient care and other institu-
tions. Thus, the published results of this group are only of 
limited value for decision making by other users since they 
cannot expect to be able to reproduce such excellent results.
On average, the revision rate data of the Oxford team have 
been 2.7 times lower than the revision rates quoted in the inde-
pendent literature, and 4.4 times lower than the results from 
worldwide registry data. This means that on average, publica-
tions involving revisions from this group only match 23% of 
the revisions documented in worldwide registers, and 37% of 
the revisions published in independent studies.
Even though one third of the clinical studies (7/22) have 
originated from the inventor group, these papers account for 
one half of all cases published worldwide. Owing to the longer 
follow-up periods, the value for observed component years 
reached 65%.
While multiple mentions of the same patients in different 
studies unfortunately cannot be excluded in a literature analy-
sis, this does not affect the impact publications have on experts 
and decision-makers. As a rule, major studies covering longer 
periods of follow-up are assigned superior value.
The implant development team in Oxford has therefore been 
clearly overrepresented in the clinical literature, which—along 
with the discrepancy regarding clinical outcome—has had a 
statistically significant influence on all the published results. 
In a conventional analysis of the clinical literature, this influ-
ence therefore represents a confounder that could also affect 
assessment of the product by stakeholders.
By contrast, the independent clinical literature puts forward 
revision rates that are 1.6 times lower than the comparative 
figures in registries. These differences can, however, be plau-
sibly explained by factors such as higher surgical expertise. In 
general, studies without participation of the developers of the 
implant can be said to have good reproducibility.
The variation in results is clearly less in registries of differ-
ent countries than it is in the clinical literature. This applies to 
both annual reports and registry-based journal publications. 
Apart from the larger numbers of cases, it is probably the min-
imization of confounding factors, which basically cannot be 
excluded in sample-based studies, that accounts for this effect. 
Moreover, the impact of a single group on the results is 
automatically limited by the wider scope of data collec-
tion. For the assessment of outcome results on orthopedic 
implants, registry data are therefore superior to clinical stud-
ies. The potential influence of national circumstances can be 
quantified and narrowed by comparing data from different 
countries.
Registry data can be used as a benchmark in the assessment 
of clinical studies, particularly when it comes to evaluation of 
whether relevant bias factors could possibly have an influence 
on the outcome. Thus, registry data can provide a valuable 
contribution to the assessment of outcome data.
Regardless of the confounding factors detected in the clini-
cal literature, registry data on the Oxford unicompartmental 
knee prosthesis indicate similar performance of this implant 
in comparison with other well-performing products for 
unicompartmental knee arthroplasty.
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